continu outpac expect underpin
posit trend rate bullish outlook
updat forecast estim aug
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research aug
estim aug
price data aug
rate updat aug
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
spent better part last decad posit
leader within healthcar servic -- acquisit
caremark omnicar recent aetna defin
strateg direct combin lead pbm retail
pharmaci top manag care franchis form three pillar
think posit firm better compet
consolid healthcar servic sector next year
cost advantag underli network effect support
firm excess econom return set strengthen
integr aetna continu come year think
cost sale synergi like exceed initi expect
firm begin serv custom lower all-in cost
rival increas attract combin medic
said think investor increasingli cautiou
evalu potenti issu aris transact
high price paid signific debt incur increas
oper risk otherwis larg stabl franchis
view follow write-down omnicar due
poor financi perform think littl room error
ensur aetna acquisit see success complex
accentu increas focu washington toward
chang current drug price paradigm open door
potenti market disrupt caremark pbm industri
final expect concern around healthcar reform pick
come quarter elect cycl begin
unfold believ firm econom moat help protect
policy-driven volatil maintain large-scal
disrupt low-prob event think like
outcom would includ privat servic provid play role
polici solut nation rise cost healthcar
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
follow acquisit aetna provid
integr healthcar servic offer member legaci
combin largest pharmaci benefit manag process nearli
billion adjust claim annual sizabl retail pharmaci boast
organ roughli million member put firm stronger
foot within payer industri posit better lower overal
cost client
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
follow upbeat result year date intend leav
per share fair valu estim unchang
valuat impli time updat estim
adjust earn ebitda respect
firm appear deepli under-valued despit forecast
larg reflect continu headwind
long pressur firm segment perform
retail segment forecast overal revenu growth
set averag annual come five year
driven growth store count same-stor comp
averag midsingl digit bulk driven
script volum persist headwind
prescript reimburs pharmaci model
approxim basis-point step-down segment margin
associ weak compani omnicar
institut pharmaci subsequ improv
margin structur busi
pbm expect revenu grow annual
clip driven growth claim off-set price pressur
mail order network pharmaci channel
consequ on-going price headwind assum
gross margin oper profit per claim
continu declin rate roughli per year
leav segment oper margin histor trough
termin forecast year
final aetna expect posit sale environ
underpin combin medic pharmaci benefit
gener membership growth
time assum segment margin structur
somewhat defend help manag outlin
opportun around cost synergi associ
assumpt result consolid revenu growth
annual consolid
ebitda margin remain near forecast
period follow debt reduct next two year
assum return share repurchas help gener
roughli ep growth long run
given scale divers oper give
medium uncertainti rate bull-cas scenario
assum firm abl grow firm-wide revenu rate
roughli basi point ahead base-cas
expect specif bulk upsid
revenu forecast driven manag price
pressur across enterpris script price
pharmaci pbm face shallow declin
base case model addit view margin pressur
within firm retail pbm segment
manag less pronounc declin
busi insur oper assum modest
margin expans integr synergi come ahead
expect oper expens growth fall
margin expand roughli basis-point forecast
period result fair valu estim per share
time estim adjust ep ebitda
respect
bear case outlook isnt absolut worst-cas
scenario think reason encapsul
on-going weak perform compani
instanc normal revenu growth enterpris fall
slightli ahead annual also assum price
margin pressur firm three busi
result segment margin emb trough-lik
assumpt perpetu consolid ebitda margin
compani fall roughli basis-point
weakest
profit experienc firm decad
expect fair valu estim fall per
share impli time estim adjust
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
caremark pbm
compani dispens one quarter prescript
fill outsid hospit help support econom
profit leverag fix cost creat synergi
order creat
cost-advantag pharmaci network within pbm
segment firm clear number one adjud
nearli billion adjust script annual addit
pbm abil consolid buy power help receiv
discount pharmaci drug manufactur
client caremark perenni low-cost
provid due size relationship pharmaci
locat view histor uniqu
combin asset think
leverag ad aetna mix pbm industri
consolid three major player
annual retent rate typic establish
three-year servic contract plan employ client
think establish weak switch cost
busi howev convinc moat
sourc would stand absent cost advantag
think strongli defin competit advantag
industri
combin pbm retail pharmaci help
creat uniqu offer help keep cost
pbm client creat valu enterpris
instanc mainten choic offer give member
option fill script mail order pharmaci
retail locat cost mail order script
help keep patient network regardless
prefer dispens method keep cost
plan sponsor think similar synergi emerg
aetna minuteclin asset own
think chang plan design encourag patient
seek minuteclin care low-acu ailment
ultim creat benefit patient
plan sponsor lower cost across board
manag intend remodel exist
ep ebitda respect
support scale-deriv cost advantag aid firm
maintain econom profit time
strateg addit aetna creat meaning cost
synergi also improv compani firm-wide
product offer combin entiti close
resembl asset mix wide-moat
view right path compani pursu
integr medic pharmaceut benefit
maintain access low-cost site care seem
direct path toward reduc cost care
client appear well way toward build
franchis focus opportun
three busi segment quit uniqu
think three reli cost advantag support
narrow econom moat pharmaci busi
front-of-stor retail busi somewhat undifferenti
like no-moat bulk segment revenu
driven pharmaci relationship patient
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
locat initi geographi higher concentr
aetna member order cater special
patient need think logic extens
strategi compani invest minuteclin
step recent year remain signific
opportun remodel exist store expand urgent
care footprint alreadi largest retail clinic chain
wide margin market share clinic count
recent addit aetna insur asset also help
support narrow moat view contend
profit back cost advantag network effect
aetna repres fifth
measur premium written like third
fourth largest membership given sizabl fee-bas
enrol mix advantag thought two
way relat back size insur book
busi first larger membership base allow
greater central fix cost leverag increas profit
potenti margin member overal enterpris
second larger membership base allow greater
negoti leverag versu provid insur
need creat plan network allow lower medic
cost per member opportun lower premium
improv benefit offer secur enrol growth
rare instanc healthcar system focus build
local scale shift balanc power
relationship given much higher
level
concentr found industri larg think
scale frequent tip insur favor
network effect also play intertwin role
patient payer provid incumb plan
enrol grow relationship three
entiti becom valuabl time patient
becom rel afford plan invest
broader swath benefit member payer
expand enrol allow greater per-memb
profit attract offer either
better price entic benefit packag
provid particip expand plan network
provid access greater patient volum key
compon profit busi high fix cost
short run dynam creat barrier entri
would-b competitor put togeth attract
price provid network new geographi prohibit
difficult without membership pool vice versa
think sourc present aetna
less convinc network effect moat sourc would stand
support econom profit
enterpris like weak network effect
associ retail pharmaci busi appear
meaning less moatworthi network
associ manag care express script exclus
walgreen loss expect
along loss network statu prime
therapeut suggest us pharmaci
network provid less overal valu compar
provid relationship manag care somewhat
intuit patient like much indiffer
fill prescript either walgreen
would switch primari care
provid due network disput
think pursu right strategi build
integr servic provid abl add
valu client sharehold cross-sel medic
pharmaci benefit provid low-cost retail mail
drug dispens get better util
urgent care asset aetna acquisit put
equal foot industri leader
give firm right combin asset better lower
cost care patient plan sponsor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
leav consolid return invest capit
margin ahead firm cost capit howev
think return exclud goodwil indic
firm organ return increment capit go forward
metric consist mid high teen leav us
confid moat trend assess
think underli moat sourc attribut
strengthen result strateg
reshap follow acquisit aetna posit
exist cost advantag like improv
gain greater control integr cost medic
pharmaceut servic sell plan employ
sponsor opportun increas narrow-network
util within pharmaci improv site-of-car usag
minuteclin
combin cost
pharmaceut medic benefit integr
cost-sel initi creat compel case
strengthen competit posit next five year
addit suggest network effect like
arent widespread enough support narrow moat rate
isol think network effect associ
pharmaci medic benefit manag like
strengthen aetna caremark come togeth
umbrella extent pharmaci
minuteclin asset see increas util aetna
plan design think valu network
end patient plan sponsor like grow alongsid
member particip network success failur
strategi depend well convinc
plan sponsor take restrict access order
legaci busi seen lower return
capit insurance-focus peer due
higher capit intens associ retail pharmaci
busi adjust leas oblig also
note invest capit growth larg driven
acquisit think value-addit
enterpris acquisit caremark
omnicar pharmaci aetna
account nearli net invest capit growth
period price asset rel high
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth firm combin aetna put
compani much attract competit
posit industri move toward prefer
integr servic offer
orec polici initi suggest potenti
chang exist rebat structur drug
distribut may risk chang would like
ocv ownership largest nation pbm provid
substanti negoti
leverag cost
advantag claim process allow best-
oth bulk insur membership growth
come year stem cohort lower-margin
headwind insur profit
oinvestor benefit meaning cost
sell synergi associ combin
lead medic benefit busi largest
pbm retail pharmaci network countri
ohealthcar reform like recur topic
throughout upcom elect cycl
could creat increas stock volatil pose real
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi posit remain reason
take roughli billion increment debt acquir
aetna think manag capit prioriti worth
watch close follow transact close
late estim firm pro-forma leverag ratio
fall north time versu histor leverag rang
time manag outlin de-lever
path believ achiev put compani
track reach debt-to-adjust ebitda ratio
time come two year assum growth
firm per share dividend pay-out addit
share repurchas combin firm
gener plenti cash reduc debt burden sizabl
amount next year anticip return
regular dividend growth buy-back activ beyond
give medium uncertainti rate follow
close aetna acquisit compani ownership
lead pharmaci benefit manag sizabl retail
pharmaci footprint top insur help de-risk
volatil underli cash flow increas
opportun firm find cost revenu
synergi segment time said
regulatori risk remain ever-pres healthcar
payer provid administr push
increas transpar healthcar marketplac
particularli relat drug channel pose
potenti risk firm pbm retail oper
give us comfort firm abil weather
potenti chang regul push structur
chang price system throughout drug distribut
would like creat headwind growth profit
shorter term hand encourag
opportun compani marri newli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
acquir insur asset lead pbm win new
busi serv insur client overal lower
price point think increas competit
firm offer like modestli improv
sticki client relationship
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
new york mellon corp
fidel manag research compani
share
fund
share
fund
although intend keep eye on-going capit
alloc prioriti event suggest
histor acquisit less stellar
said think ceo larri merlo done
otherwis admir job lead busi ever sinc
pharmacist train merlo involv
sinc instrument firm
transit true healthcare-focus organ
think aetna transact like defin time
ceo expect success importantli mani
key aetna leader stay follow transact
includ firm presid karen lynch lead
busi unit former compani ceo mark bertolini
join board director
addit strong leadership team enterpris
think board put place strong compens
program align incent manag
sharehold bulk merlo compens driven
equiti incentive-bas award comprehens
set goal think consist build
intrins valu firm annual cash bonus tie
firm-wide oper profit along custom satisfact
measur pbm retail segment equiti
grant focus three-year measur return net
asset similar focu return capit rel
total sharehold return addit board recent
introduc perform stock unit vest three
year tie ebitda target
signific factor assess
appreci firm polici separ role board
chairman ceo
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
bull case remain intact result
report second string strong quarter
follow acquisit aetna late updat
model contempl better-than-expect perform
to-dat manag modestli higher ep outlook
year forese substanti
chang per share fair valu estim
narrow-moat name remain territori current
trade near time higher earn outlook -- share
remain attract opportun view
saw last quarter retail pharmaci segment
continu post better-than-anticip growth led
same-stor script volum expand firm
expand particip pharmaci benefit manag
narrow network offer help acceler script
growth last year half notabl front store
sale also acceler nice nearli same-
store basi adjust calendar varianc versu last
year help somewhat extend flu season
pbm script growth line
expect although segment margin held much
better origin expect per-script profit
expand modestli year date despit initi
onboard volum -- assum mid-
single-digit declin year
manag care franchis continu perform well
overal medic enrol continu grow modestli
first quarter segment geograph
expans medicar advantag marketplac
continu propel membership higher
busi post medic loss ratio quarter
consist expect although
year-to-d figur help modest favor
reserv develop overal full-year result track
modestli ahead initi estim well within
manag initi outlook call
view compani earli post-merg result
continu underscor posit moat trend rate
combin entiti integr aetna add cost
advantag underpin narrow econom moat
profit busi segment outpac
expect help realiz synergi led
earn beat roughli compar
estim manag revis ep outlook full
year impli higher-than-anticip third quarter
lower project fourth quarter given season
pattern busi overal approxim
midpoint year look somewhat conserv rel
result thu far surpris see
addit upsid come month
last quarter highlight weaken retent rate
pbm on-going sell season
potenti caus concern time howev
pleas see manag report billion
improv net new busi compar figur
report june analyst day help grow
new win improv client retent last two
final outlook pbm industri larg
somewhat de-risk administr juli decis
abandon depart human servic
propos polici chang drug rebat practic pleas
see report rebat rule dead suppli chain benefit
drug firm pressur in-depth review
industry-specif effect unexpect shift
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
addit detail analysi effect
rebat rule elimin pleas see report rebat
first-quart result support bullish view
narrow-moat report first-quart result
surpass expect strength broad base
adjust profit meet beat
expect firm three segment
improv same-stor perform retail acceler
growth medic enrol aetna provid earli
indic benefit merger begin
take root underpin posit moat trend rate
mani move piec consid updat
model dont forese make sizabl chang
near time current adjust earn estim
remain compel opportun long-term
provid
comprehens long-term outlook busi next
month investor day may result discuss
provid earli look strategi progress
initi pilot firm health hub strategi appear
hit mark compani intend fill
houston servic market health hub account
store base area scale
script growth across enterpris standout
follow disappoint result walgreen releas
week ago retail post same-stor script
volum nearli follow growth rate
although note pharmaci reimburs
track toward estim declin
full year
caremark claim volum grew although
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
note weaker anticip retent pbm
sell season compani indic retent
perform fell consist near
import metric watch throughout rest
season next year sticki pbm
relationship help support narrow moat rate
firm-wide result manag commentari give
us confid posit moat trend rate
franchis profit compani retail
busi like suffer bulk year driven
primarili weak firm long-term care
indic chang made
omnicar track produc cost save time
addit note last quarter initi million
synergi target associ aetna merger track
surpass end think effort
help support notion mark low point
overal return capit report combin entiti
model impli acceler econom
profit come five year
asid transaction-specif synergi manag
also quantifi recent discuss enterpris cost
save initi help support competit
posit retail segment creat compel
offer firm variou constitu drive
bottom-lin growth time effort help
improv compani cost structur billion
billion run-rat basi repres roughli
upsid current oper profit estim
wait see initi progress
next year effort underscor favor
assess cvs/aetna combin
modestli ahead billion estim
full year put firm track reach net leverag
ratio near time end
fair valu chang across board
taken fresh look managed-car industri
come away bit construct health insur
broadli rais moat rate unitedhealth
wide narrow narrow none
respect addit revisit industrywid
neg moat trend outlook bump unit stabl
weve assign posit trend rate
larg attribut competit benefit expect
busi achiev integr aetna
express script respect
unit rais fair valu estim per
share larg driven moat upgrad
optimist long-term assumpt franchis
think unit uniqu deserv wide moat rate
driven cost advantag network effect
embed within largest privat health insur
organ nationwid unriv scale allow firm
price insur book commensur lowest cost
per insur member firm cover led
industry-lead gain membership past five
think merger creat
organ deserv narrow moat rate result
rais fair valu estim per share
think combin medic
strateg
sound underpin posit trend rate integr
execut
out-performance
final manag indic alreadi repaid roughli
billion debt follow transact close late
final trim fair valu estim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
like strateg decis bring
togeth think firm expos
idiosyncrat risk three busi
account roughli firm-wide oper profit
estim leav expos policy-driven chang
percol within pbm industri addit
transact complet cusp lose
largest custom manag took
account evalu valuat busi
like open door increment unknown
run-of-the-mil megamerg given rel higher
estim uncertainti think
unit offer attract risk-adjust return
per share account recent result
manag outlook came
expect larg attribut weak no-
moat retail long-term care segment think aetna
transact ultim lead improv competit
posit appear trend ahead initi
point investor toward unit highest-
convict idea trade compel discount
revis estim intrins valu unit
current trade near time estim
adjust earn investor opportun buy
above-averag busi below-averag valuat
firm diversifi oper make less prone
regulatori disrupt peer view lead
posit insur ambulatori care data analyt
pharmaci benefit give advantag competitor
find hard replic best-in-class busi
combin exemplari stewardship give us confid
long-run trajectori firm think
stapl investor healthcar portfolio
outlook bit muddi firm
pharmaci busi cater long-term care market
continu period prolong weak
view core firm thesi would
encourag investor look volatil toward
long-term earn power combin
aetna think transact put firm nearest
unit term competit posit although
relianc pharmaci pbm oper make somewhat
prone regulatori disrupt stock trade
time estim adjust earn
market appear take pessimist view
opinion -- despit reduct fair valu stock
remain territori
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
